Please standby. Your meeting is ready to begin. Please be advised that this conference call is being recorded. Good morning, ladies and gentlemen. Welcome to the Manulife Third Quarter 2023 Financial Results Conference Call. I would like to turn the meeting over to Mr. Hung Ko. Please go ahead Mr. Ko.

Thank you. Welcome to Manulife's earnings conference call to discuss our third quarter and year-to-date 2023 financial and operating results. Our earnings materials, including the webcast slides for today's call, are available on the Investor Relations section of our website at manulife.com. Turning to slide 4. We will begin today's presentation with an overview of our third quarter results and strategic update by Roy Gori, our President and Chief Executive Officer. Following Roy's remarks, Colin Simpson, our Chief Financial Officer, will discuss the company's financial and operating results. After the prepared remarks, we'll move to the live Q&A portion of the call. Before we start, please refer to slide 2 for a caution on forward-looking statements. Note there are material factors or assumptions applied to making forward-looking statements, and actual results may differ materially from what is stated. I would also refer you to slide 35 for a note on the non-GAAP and other financial measures used in this presentation, which includes an explanation of our use of transitional results for 2022 comparison. With that, I'd like to turn the call over to Roy Gori, our President and Chief Executive Officer. Roy?

Thanks, Hung. And thank you, everyone, for joining us today. Yesterday, we announced our third quarter 2023 financial results. Let me first share with you some quick thoughts on the quarter. We delivered growth across our global business, which is evidenced through the strong operating and new business results. In the third quarter, we saw double-digit growth in APE sales and new business value compared with the prior year quarter. We also generated solid growth in new business CSM of 6%, which contributed to an annualized organic CSM growth of 5% on a year-to-date basis. Since the adoption of IFRS 17, we've been delivering steady year-on-year growth in core earnings over the past three quarters, including a 35% rise in core EPS this quarter. We also reported core ROE of 16.8%, ahead of our medium-term target of 15% plus for the second consecutive quarter. And we continue to focus on allocating capital to our high return businesses to drive ROE growth. Despite the impacts of the challenging macroeconomic environment on our net income, we grew our IFRS 17 adjusted book value by over $1 per share in the third quarter, which translated to a 4% increase year-on-year. And finally, enabled by our strong capital position, we continued to deploy capital to further enhance returns to shareholders through dividends and share buybacks. Turning to slide 7, we are driving profitable growth, while focusing on the needs of our customers and returning capital to our shareholders, which contributed to a strong third quarter. Asia continued to build on the momentum of the previous quarter, capitalizing on the return of demand from Mainland Chinese visitor customers, and delivered strong new business results, with APE sales and new business CSM growth of 20% and 16% year-on-year, respectively. In Canada, we delivered impressive APE sales growth of 51% compared with the prior-year quarter, driven by a large affinity market sale, which translated into an increase in new business value of 72% in the segment. We're also making decisions easier for our customers. Notably to accelerate the growth of our global high net worth business. We launched a unified onboarding platform in the third quarter in Bermuda, Hong Kong and Singapore to deliver a consistent high-touch experience for both distributors and customers. I'm encouraged by the continued growth across our global franchise. Now let me speak to our continued journey of becoming a digital customer leader and highlight some of the key initiatives across our businesses. Starting with Canada, we continued our digitization efforts to meet growing demand for more personalized digital health care experiences for our group benefits members, with a strategic partnership with League, a leading healthcare technology provider. This partnership will help our customers understand their health, focus on prevention, access care, and better understand and optimize their benefits. In global WAM, we accelerated customer adoption of digital applications in Canada retirement through our Say Goodbye to Paper campaign, which contributed to a 165% increase in members converting to e-statements over the three-month campaign period and an increase in satisfaction in their digital experience over the prior quarter. Moving to Asia, we further automated our claims handling process in Hong Kong to deliver a better customer experience and drive operational efficiency. Through continued leveraging of data to enhance our auto adjudication engine, the initiative drove a nearly two-fold increase in straight-through processed claims year-on-year. In the US, we continued to optimize our digital capabilities to create a more seamless digital customer experience through various initiatives, including an enhancement of the interactive voice response authentication, enabling 31% of inbound calls to be completed with no human interaction during the quarter. These are just a few recent examples of how we're making decisions easier for our customers and meeting their personalized digital needs as part of our investment of more than $1 billion since 2017 to digitize our business. Looking ahead, we'll continue to build on our strong digital platform while accelerating our adoption of new technologies such as generative AI. We're already piloting a number of initiatives that we will look to scale as we uncover their potential to generate top and bottom line benefits. Moving to capital management, we continue to maintain a strong capital position supported by a higher LICAT ratio in the quarter of 137%. We also generated stable growth in adjusted book value per share with a 4% increase year-on-year in the third quarter. Coupled with a financial leverage ratio that is close to our medium term target of 25%, we are in a position of strength to weather the macroeconomic uncertainties and continue returning capital to our shareholders. In fact, we've returned approximately $7.7 billion of capital to our shareholders through dividends and share buybacks since we resumed our share buyback program in 2022. And our dividend per common share has grown an average of 10% annually since 2017. In summary, I'm pleased with our strong results in the third quarter. While we continue to operate in a tough and uncertain environment that presents challenges, I see tremendous opportunities against the backdrop of higher rates and continued recovery in Asia. Manulife is uniquely positioned to capture these opportunities, given our financial strength, business and geographic diversity, and a leading insurance business that will continue to benefit from higher rates. Thank you. I'll now hand it over to Colin to review the highlights of our financial results.

Thanks, Roy. We have indeed delivered strong performance in the third quarter with growth in sales, earnings, book value and capital. I'll go into a little more detail on our results before we move to Q&A. I'll start with our top line on slide 9. APE sales increased 21% from the prior quarter as we continue to capitalize on the return of demand across Asia, in particular Hong Kong. In Canada, we delivered APE sales growth of 51%, driven by a large affinity market sale. The strong growth in sales translated into an increase in new business value of 15% and contributed solid growth in new business CSM of 6%. This reflects increases in sales of Asia and Canada, offsetting a decrease in the US, which experienced a slowdown in demand for accumulation products. Global WAM saw net outflows of $800 million entirely due to a large case pension plan redemption in our US retirement business. Year-to-date, we've generated net inflows of $5.8 billion. I'm encouraged by the continued growth across our new business metrics compared to 2022 in the face of relatively difficult economic conditions, a testament to the demographic tailwinds in many of our markets, our broad product offering and our ability to execute. Moving to slide 10, which shows the strong growth in our profit metrics. Core EPS increased 35% as we grew core earnings and bought back shares. Now, this growth was flattened by the hurricane-related charge in our P&C reinsurance business in the prior-year quarter. But normalizing for this, core EPS still increased 12% despite a significantly higher credit charge. As Roy mentioned, active capital allocation is a key priority for us and it is encouraging to see our third quarter core ROE increase to 16.8% ahead of our medium-term target of 15% plus for the second consecutive quarter. Turning to slide 11, our net income was lower than core earnings this quarter caused by the challenging investment environment, but it is important to consider that some of this adverse result was offset by gains in other comprehensive income, or OCI, which contributed to the increase in our book value. Together with the contractual service margin, which also increased, we reported an adjusted book value per share of $30.67, up 4% year-on-year. Bringing back to our core earnings results, slide 12 shows our drivers of earnings analysis presented relative to the prior-year quarter to give you a sense of our progress. The first point to note is the recovery in the core net insurance service result. This was driven by the non-repeat of last year's $256 million hurricane charge, but also improved insurance expense. The second point is that higher interest rates continue to benefit our net investment result through both higher expected investment earnings and higher returns on our surplus assets. These two factors were partially offset by high debt costs included in another core earnings, along with higher performance-related costs and investments in technology across our businesses. Finally, the increase in expected credit loss, or ECL, this quarter was primarily related to certain electric utility bonds impacted by the Hawaii wildfires and a handful of private placement loans. These factors drove a 28% year-on-year increase in our core earnings as shown in the next slide, which I'll move to and discuss on non-core items. The challenging macroeconomic environment led to a $1 billion market experience net charge in the third quarter. This included a $400 million charge from lower-than-expected returns on ALDA, a $273 million charge due to lower-than-expected public equity returns during the quarter and the $266 million loss in derivatives and hedge accounting ineffectiveness, driven by the significant increase in rates and steepening of yield curves where the 10 and 30-year rates increased more than 70 basis points while the shorter rates between 1 and 5 years rose on average 30 basis points. We will continue to refine our hedge accounting programs to better align with economic hedges. I will also note that, given the interaction between the fair value through OCI option on our assets and liabilities and derivative hedge accounting, it will be important to look at the impact on this line in conjunction with movements in OCI to see the full picture of interest rate impacts. For this quarter, the impact was net favorable. While we reported a net charge in ALDA reflecting lower than expected returns, the portfolio continued to generate a positive return in the quarter. Our long-term track record supports our ALDA return assumptions, but we should expect some periods such as now where it may underperform the long-term assumptions. Commercial real estate was again the biggest driver of our ALDA underperformance as higher long-term risk-free rates are pressuring valuations. Although higher capitalization rates used by third-party appraisers lowered current valuations, these higher rates also indicate higher returns going forward, which further increases our confidence in achieving our long-term assumptions prospectively over time. It is important to reiterate that we continue to view a diversified ALDA portfolio as well suited for insurance liabilities, with attractive returns and lower volatility relative to both credit and equity indices over the medium to long time horizon. Outside of the market experiences, I would like to note that our annual review of actuarial methods and assumptions or basis change had a net neutral impact on net income attributed to shareholders. This year's basis change resulted in a net favorable impact of $347 million pretax, reflecting a neutral impact to net income and increases in OCI and CSM. Further information on basis change is available in the appendix to the presentation. Lastly, the $306 million gain in reinsurance transactions, tax-related items and other reflects a one-off release of multi-year tax provisions. The next few slides will cover the segment view of our results starting with Asia on slide 14. Both top and bottom line performances were strong. APE sales increased 20% from the prior-year quarter, reflecting a return of demand from mainland Chinese visitor customers, which you can see in our Hong Kong results. As we have mentioned previously, the pace of economic recovery in Asia is uneven and the strength of our diversified business in the region continued to shine through. The increase in sales contributed to a 16% and 7% growth in new business CSM and new business value respectively. We delivered strong core earnings growth in Asia of 33% year-on-year, primarily driven by higher investment yields and business growth as well as product actions. But I would add that core earnings also benefited from an increase in amortization of CSM in our Hong Kong business as a result of the basis change. Moving over to the Global WAM segment results on slide 15. Our Global WAM business reported net outflows of $800 million. This was driven entirely by a large case pension plan redemption in US retirement, which more than offset continued strong inflows in our institutional business. Excluding this large case pension plan, net inflows were $4 billion for the quarter. Retail net outflows in the quarter reflected lower demand as investors continued to favor short-term cash and money market instruments amid market volatility and higher interest rates. Despite this backdrop, our US retail net flows outperformed the industry average. Our Global WAM business also delivered resilient core earnings supported by higher average AUMA, which increased 4% year-on-year and higher than usual institutional performance fees. Our core EBITDA margin of 26.9% has improved sequentially since the first quarter of 2023, driven by steady growth in average AUMA and higher institutional performance fees. Heading over to our Canada segment on slide 16, which had another strong quarter, APE sales increased 51% compared with the prior-year quarter, primarily due to a large affinity market sale, which was the main contributor to our significant growth in new business value. I would like to remind you that the majority of the affinity market sales are classified as premium allocation approach, or PAA, contracts which do not generate CSM. Core earnings increased by 4% compared to the prior-year quarter, mostly driven by more favorable insurance experience in our group benefits business. Moving to slide 17 which illustrates our US segment's results. In the US, lower APE sales were driven by the backdrop of a continued high rate environment, adversely impacting our accumulation insurance products in particular, especially for our affluent customers. Lower sales contributed to the lower new business results. We're actively broadening our product base to mitigate the headwinds, including the recent expansion into the employer market by introducing a multi-life product. Our US business delivered resilient core earnings which decreased 2% compared to the prior-year quarter, mainly reflecting the increase in ECL. Insurance experience improved year-on-year from net favorable claims experience, which provided a partial offset to the credit impact. On to slide 18. We continue to maintain a strong balance sheet and capital position. This underpins the commitment we made to our customers with every policy, solving gives us financial flexibility. At the end of the quarter, we had $22 billion of capital above our supervisory target ratio, and our higher LICAT ratio of 137% remains strong. Our financial leverage ratio declined by 0.6 percentage points year-on-year, largely driven by higher adjusted book value during the quarter, and this continued to track closer to our medium-term target of 25%. Enabled by our strong capital position, we continue to return capital to shareholders. We've returned approximately $7.7 billion of capital to shareholders through dividends and share buybacks since we resumed our buyback program in 2022, including approximately $420 million of buybacks or nearly 1% of our outstanding common shares during the third quarter. And finally, moving to slide 19, which shows how we're tracking against some medium-term targets. Our CSM growth metrics are below our medium-term targets, partly due to the impacts of market and foreign exchange movements. We continue to explore products and business enhancements to improve CSM growth, and are still optimizing our performance in a post-IFRS 17 world. Our core EPS growth and core ROE have been strong in the first nine months of 2023 and above our target ranges. All in, we've delivered strong operating and new business results. And echoing Roy's earlier remarks, as we continue to face an uncertain global macroeconomic and geopolitical environment, I'm confident that we are well positioned to deliver for our customers, shareholders and colleagues. This concludes our prepared remarks. Before we move to the Q&A session, I would like to remind each participant to adhere to a limit of two questions, including follow-ups and to requeue if they have additional questions. Operator, we will now open the call to questions.

And the first question is from Meny Grauman from Scotiabank.

Your WAM business benefited from higher than normal performance fees in institutional business. I was hoping you could provide us a little bit more color in terms of what was driving that. And I was wondering if you could scale that in terms of dollars.

It's Paul here. Yeah, in the quarter, we did have a strong performance fee. It was on our timber business. The performance fee was $23 million post-tax this quarter that helped contribute to the positive results. But if you look at the underlying core earnings, they were strong without the performance fee. If you compare them to Q2, if I back out the performance fee completely, core earnings would have been $338 million, up 6% from Q2, EBITDA margin would have been 25.6%, which is 100 basis points up from Q2 and that's relative to average AUMA up 1% from Q2. Now, having said that, performance fees can be lumpy, but we would expect to generate a certain level on a regular basis. Historically, for us, that – over the last four years, that's been between on average $10 million to $15 million post-tax on a 12-month basis. This year, year-to-date, we're sitting at $27 million post-tax, a little bit higher than normal. But if you're trying to get a sense of run rate, you should include some portion of performance fees on an ongoing basis.

Just wanted to talk about CSM. New business CSM growth and CSM balanced growth both year-to-date coming in well below medium-term targets. So just wanted to revisit that what's driving that? And then trying to think through the implications in terms of earnings and book value growth going forward? So those would be the two questions on CSM.

It's Colin here. We're actually really pleased with our new business CSM growth in the quarter. 80% is coming from Asia, and Asia is up 16% year-on-year. So there's good momentum coming from Asia and that will feed through into the CSM balanced growth. If you look at the CSM balanced growth in the quarter, on an organic basis, it's up 5% annualized, that's year-to-date, actually, annualized 5%. So we have got momentum in our CSM balanced growth. It isn't quite at the 8% to 10% target that we're going for. But we're very focused on this because, as you know, this is our store of future earnings and this will drive through into future earnings. So really nothing new to say on our target. We continue to operate in an IFRS 17 environment, and there's only three quarters of reporting. So, we're still getting used to that as a reporting regime, but remain very confident on our medium-term targets.

I might just add in as well. I think Colin summarized it well. But we're still very much committed to our medium-term targets for both new business CSM and CSM. Obviously, we're still in the early days of IFRS 17. And it's a challenging environment, as Colin highlighted. But there's a lot for us to be encouraged by, particularly the fact that our new business CSM for Asia was 16% in the quarter and 12% year-to-date. And as Colin highlighted, more than 70% – in fact, 80% of our new business CSM is coming from Asia. So we still feel very confident in our medium-term targets, which are through the cycle. And there's a lot to be optimistic about as we look to the next year and beyond.

Just a follow-up in terms of – obviously, you're reacting to a market environment, but is there anything – any levers that you can pull internally in order to boost those growth numbers? So curious about actions that you can take or are taking to do them?

I think, Meny, for us, it's really about more customers through the door, more sales and better margin. If we get that taken care of, then everything else flows from there. So that's really what we're focused on.

The next question from Doug Young from Desjardins Capital Markets.

Just maybe starting with Asia. It looks like there was – lapse was an issue again in Vietnam. I think that's been the case for a few quarters now. Can you maybe delve into a bit of what the issue is and the reserves need to be adjusted on that business? And then, I guess on the flip side, in Asia, it also looks like there was some negative claims experience. And taking this from just slide 25, if you can kind of dig into that a little bit, what drove that?

This is Phil, I'll make a start and then hand over to Steve Finch who may wish to comment further. But to your first point on Vietnam, the market has been experiencing challenges. And we've referenced this in previous quarters. But it really is a reflection of the underlying challenging economic conditions in Vietnam. And we're seeing that translate into lower new business volumes, but also lower levels of persistency. And when you look at the movement in policyholder experience in the CSM, that's really a reflection almost in its entirety of the challenging persistency that the entire industry is seeing in Vietnam and where we're seeing that as well in our business. You also referenced policyholder experience or experience elsewhere. And in the P&L, you do see a negative $20 million in Asia. I do want to clarify that that exclusively relates to maintenance expenses. So our policyholder experience, there are positives and negatives across the region, but it all balances out to a net neutral position. And when you look at the impact of expenses and compare the overall expense position relative to the third quarter of 2022, what you'll notice is there's been a reallocation of unattributed expenses to maintenance expenses. So that $20 million is actually geography rather than a deterioration in the expense position.

And also adding the claims was neutral for Asia across the region overall. Specifically, Doug, with respect to your question on reserving, as Phil noted, the persistency challenge across the industry in Vietnam, that's expected to be short-term in nature. We don't think it's a structural issue when we've got a strong position there. So it's not really a long-term assumption balance sheet issue. And that's why it's not reflected in the basis change.

Steve, while I've got you, just on the long-term care insurance, I know it was a net modest positive, exactly like last quarter, a little negative in the P&L, a little positive in the CSM. Can you unpack a bit about what's going on to the P&L, walk through the CSM? What you're seeing, is it exactly the same as last quarter? And is this something that we should expect to continue for this block of business where we see a little drag in earnings, but a little bump in CSM, just trying to understand how to think about the moving pieces with this business?

On long-term care, in total, which is really how I think we need to look at it at experience to understand the drivers, LPC was a modest positive. It's also been a modest positive, since the assumption review in 2022. And just take the chance to emphasize, you know how we've been managing this business over time, regularly updating to reflect experience, and we've been doing that for a couple of decades. Whereas under the new US GAAP standards, that's a new requirement. So we've been managing it that way for years. In terms of specifically what's going on in the quarter, what goes through the through net income is cash variances. So it's higher utilization for customers on claim, but that's more than offset by favorable incidents and termination experience. And that particular trend is likely to continue over the short term, but, again, I look at the experience in aggregate, which has been positive.

Just the termination, when you say favorable termination, is that more lapse? Is that…?

It's the combination of lapse and mortality or active life and those on claim.

The next question is from Tom MacKinnon from BMO Capital Markets.

One quick question on the affinity sale. Can you quantify the amount?

It's Naveed Irshad here. So this was our largest affinity sale ever, was the Ontario Medical Association. 36,000 new customers, $150 million to $160 million of premium.

Sorry. $150 million to $160 million?

Between $150 million to $160 million of premium.

With respect to the US, like we're having some negative sales momentum here. If I look back in the history of Manulife, it was a second to die, no lapse guarantee, then moved into vitality. The consumer is changing here, just rate environment is changing. Your sales are slipping here. What are you trying to do in order to revamp sales? And what is your competitive advantage?

It's Brooks Tingle. Over the past few years, we've really worked to significantly improve the new business profitability, the profitability of our new business franchise, and notably, we've been able to grow sales during that period. And that was really on the back of our unique differentiator vitality, which you mentioned. So we've had a few years now of steadily increasing margins, increasing sales. This year, and Q3 in particular, has definitely been a challenging market. And Colin touched on it earlier. If people buy life insurance in the US, generally, for two reasons, protection against loss of income or state taxes, what have you, or accumulation, particularly wealthy people that may have maxed out their 401(k) and so forth will put money into life insurance and accumulate it for retirement. Higher interest rates, which obviously good for our business in a range of ways, challenge those accumulation sales. They're attractive alternatives for wealthy people to put cash right now. So protection sales have held up pretty well. But our accumulation sales have really been hit hard. I will say we've maintained margins throughout all of that, and we actually feel really good about our competitive position. Coming out of COVID, vitality continues to be extremely popular both with brokers and consumers, and specifically in terms of what we're doing. Colin touched on a notable action as we enhance and revamp our product lineup to reflect the current market. We launched this multi-life solution, which is a protection-based solution with vitality integrated in it. And we've seen a very, very positive and strong market reaction to that, and feel quite good about our ability to deliver profitable growth in our new business franchise in the US.

I might just also add that, despite the challenging quarter, NBV for our US business year-to-date is up 4%, core earnings is up 6% year-to-date. And as Brooks highlighted, our vitality proposition actually is a significant differentiator for us and has allowed us to outperform the market over actually quite a number of years. So, we feel really good about our US business. Challenging market at the moment with higher rates, as Brooks highlighted, but we feel optimistic about the outlook bear as well.

And if I could, just a quick one with respect to the actuarial review, lapse continuing to be an issue in the US, did you revisit the lapse assumptions for your no lapse guarantee or secondary guarantee products in the US? Was that part of that review? Or is that come next year?

The US lapses were not part of the review this year. They are part of next year's review. And let me give you a little context for what we're seeing. Reminder that before the pandemic, our lapse assumptions were up to date. Experience was consistent with our assumptions prior to the pandemic. During the pandemic, we saw lapse rates on protection products drop in Canada and the US. And that would include NLG and other protection-oriented products. What I expected to see over time is that those lapse rates would trend back to pre-pandemic levels. And indeed, that is what has happened in the Canadian level cost of insurance UL products, which is quite similar to the US no lapse guarantee. It's happened in seg funds and variable annuities. And then in the US, while lapse rates remain low, in the past couple of quarters, we have seen on some of our protection products, those lapse rates trending up. So all of this informs my expectation that, over time, we do expect the lapse rates to return to pre-pandemic levels. And this type of phenomenon is also something that we observed in the global financial crisis and coming out of the global financial crisis.

The next question is Gabriel Dechaine from National Bank Financial.

I've just got one question actually about the ALDA portfolio where another negative performance period here. We get what's going on with CRE in particular? My question is about the – when would you start to review the expected investment income, the thing that goes through your DOE, the component that's tied to ALDA? It looks like you assume a 9.5% return going forward. And historically, that's fine. It's supported by that, but those were ultra-low interest rate periods. And you do give some sensitivities about a 10% sudden drop. My question is, what if you brought that return down to 8%, to the 9%? Would I just apply that decline to the $40 billion alternative portfolio and divide by 4 and that would be the reduction to your expected investment income?

It's Scott. We, over time, expect the ALDA returns to be somewhat volatile. We're not going to hit our expected return every quarter. And as you mentioned, over time, we have achieved those returns that we put into core. We will have periods, however, of underperformance and periods of overperformance. And if you look over history, about half the time our performance is above, about half the time the performance is below. We're in one of those periods right now where the performance is below the last five quarters. We've been a bit below now. Now, our gross returns are still positive. We just have not achieved the long-term target returns. But the eight sequential quarters before that, returns were above our long-term targets. So we think those long-term targets are still appropriate. The big driver in the last five quarters of the underperformance has been our real estate portfolio, as you mentioned. It's about two thirds of the underperformance. And what's driven that are a couple of things. One office, as we know, has performed poorly. But the second big driver, and the big driver more recently, has been rising cap rates reflecting the higher interest rate environment. And as cap rates go up, that does depress current returns, but it portends higher returns into the future. And to your point, we did benefit from lower cap rates historically over the last 10 years. But you may recall that, in 2018, we did reduce those assumptions that we've put through core to reflect – even though we had hit the target returns, we were less confident we would achieve them going forward, given the cap rates had come down. We're actually now in the opposite situation. And the underperformance in the last few quarters is largely due to these rising cap rates and that will lead to higher returns going forward. So, as Colin mentioned in his introductory remarks, we're more confident than ever of achieving those long-term returns.

I get that. If we are in a higher for longer rate environment or moving towards that, seems to be the case today anyway, some of these asset classes, not just CRE, might not be able to generate the returns you have historically. And if investors want to take a more conservative view, I'm just trying to mechanically figure out what would your expected investment income look like. If that ALDA portfolio return was lowered from 9% to 8%, is there any way you can ballpark that?

It's Colin here. We're very transparent about all the sensitivity. You will see the number in the – and you actually pointed it out. So you can take a rule of thumb and divide that 10% sensitivity by however much you want to do to analyze the impact of a reduction in expected long-term returns on ALDA.

The other thing I would add, Gabriel, is that our ALDA portfolio is a diversified portfolio. We've got real estate. We've also got private equity, timber, agriculture, infrastructure, energy. So the diversification of our portfolio is very helpful. And, yes, higher rates are certainly providing a headwind from a cap rate perspective on the commercial real estate portfolio, which, as Scott highlighted, should actually give us more confidence around our return assumption in the future. The other components of our ALDA portfolio actually benefit from a higher rate environment. And in fact, in 2005 and 2006, we saw higher rates as an environment. And our ALDA portfolio outperformed assumptions. So, again, I'd just remind you that ALDA is a long-term assumption. It's through the cycle, and we have strong conviction with our assumption.

The next question is from Paul Holden from CIBC.

First question, continuing with ALDA, is maybe you can give us a sense of how much cap rates have been revised, whether it's year-to-date or sort of over the next 12 months? Just to give us, I guess, also a sense of how much further they may or may not change.

It's Scott again. So far, year-to-date, we've seen in North America cap rates rise about 60 basis points. And we're now at nearly 6% go-forward cap rates. And if you think about the return on the portfolio, it should be the cap rate plus the growth. And so, with that sort of math, we are above our long-term expectations. Our long-term expectations for real estate are among the lower ones we have. So they're below that 9% sort of on average return that we have. Now, going forward, it's a good question. What are cap rates going to do from here? And while I don't have a crystal ball, I would say that if rates stay high, we probably will see continued pressure on cap rates. I think the appraisers sort of need to get confident that central banks are going to start to reduce rates. And once they get that, I think you'll see the cap rates stabilize and at some point probably compress.

Just looking at the core expected returns and then kind of comparing it to the investment income reported on the income statement, there's a pretty big difference in the year-to-year growth rates, right, 24% on the core per DOE versus a 5% increase in the income statement. I think about that and I look at the 24% for what I think would be a long-duration fixed income book, it seems high. So, I'm just wondering how I can reconcile the two and really understand the rapid or significant increase in core investment income year-over-year.

It's Colin again. If you look at interest rates, the actual interest rate impact coming through that line is only $43 million year-on-year. There is quite a large component from business growth. And then there's a couple of ins and outs from – as we adopted IFRS 17. So there's a lot of things going through that business line, but the combination of interest rates and growth is really driving the overall increase.

And again, just adding, the go forward, we're at a good jumping-off point. And that'll continue to grow as our business grows as the balance sheet grows.

The next question is from Lemar Persaud from Cormark. Securities.

I want to turn to the credit losses. Would it be fair to suggest that you're adequately reserved for both the electric utility bonds and private placement loans? Or could there be additional losses on these exposures moving forward? And then, can you provide some additional color on the nature of these private placement loans? Like, what's the size of the portfolio? What's your provisioning against that? Any additional color would be helpful.

It's Scott. ECL was a bit higher this quarter than we normally would expect. And I'll just remind you that when we look at ECL, we're not looking at gross credit losses. Under IFRS 4, we looked at credit losses versus expectations. So you should expect to see credit losses on an ongoing basis. That's sort of why we put it into core. It doesn't net to zero. So you should expect some credit losses. This quarter, it was a bit high. And you pointed out the primary reason was Hawaii Electric and its subsidiaries. And so, that was about half of the increase. And that was due to Hawaii Electric getting downgraded significantly, and so moved to stage 2 lifetime reserve. And is that enough? Our experience with senior utility bonds, I don't think we've ever had a loss on senior utility bonds, went through a fairly similar experience with Pacific Gas and Electric and ended up with a complete recovery after they – and they actually filed for bankruptcy because of the wildfires. We feel good about it. With that said, you can never be sure as to what happens here. But we feel pretty adequately provisioned at this point. The rest of the provisions, I would say, are on a variety of different – none of them are extremely large and are kind of more in the normal course. And I would say we tend to be conservative when we put up provisions or downgrade securities. So I feel very comfortable with where we have the ECL at this point.

And these private placement loans, are they kind of related to this electric utility bonds? Like, are these separate exposures?

No, these days would be separate. There'd be a bunch of different bonds across the portfolio.

My next question is, is it plausible that we could go through 2024 and 2025 with ALDA continuing to drag down reported EPS? So we should kind of think of the starting point for reported EPS to be below core? Or it's plausible for it to be below core for an extended period of time? And then, of course, we layer everything in on – everything else that impacts the rest of the macro factors in and above that starting point for an ALDA charge, is that the right way to think about the gap between reported and core looking forward for the next couple of years.

I would suggest that – it's hard to forecast the future, of course, and the shorter your time period, the harder it is. We feel very confident in the long term that reported and core will be the same with our ALDA experience. I guess I would be a little concerned for the next quarter or two that we see cap rates go up and continue to weigh on the real estate portfolio. Beyond that, my hope and expectation, unless we see a recession or something like that, that we would get back to our long-term returns.

The next question is from Darko Mihelic from RBC Capital Markets.

Just a couple of questions on Asia. Maybe if you could provide a little bit of color. This is more of a modeling question actually. The basis change that ended up creating a higher CSM amortization, maybe if you could provide a little color on that. And is this new higher level sustainable? And similarly, I believe you did some pricing action, but I just want to confirm that.

This is Phil. I'll make a start and then hand over to Steve with respect to the basis change. And I think what you're getting at is the very strong contribution to core earnings. Colin referenced this in his remarks. We've seen a 33% growth in core earnings in Asia in the quarter. That's 13% sequentially. And one component of the growth there was the impact of changes in actuarial methods and assumptions. But I think it's really important to put that into context that off the 33 percentage points of growth, it was about 7 percentage points of growth that was coming from basis change items. The remainder of the growth was coming from commercial factors. And I think what we see in the third quarter is a very good foundation to project from for the future. And when you reflect on our year-to-date core earnings growth for Asia, that's been 10%. And I do think there is upside to that 10% rate of growth from factors, such as the opportunity for stronger productivity in our agency channel, as well as the continued emergence of the MCV channel post pandemic. I think there are, of course, always headwinds. We've talked about the ongoing challenges that the industry has seen in Vietnam. We've seen new regulations coming from the regulator in China, which we expect to impact short-term banker momentum. But overall, I do feel positive about the sustainability, not just of Q3, but also growth from there.

What we're seeing in Asia from the assumption review falls in that bucket that we call other methods and assumptions. And what this primarily relates to is under IFRS 17, we've been refining some of our models, and in particular, the cost of guarantee calculation on par, which is a new requirement under IFRS 17. So, through the year, we actually changed how we manage the business in terms of how we pass experience back through dividends to customers. We updated the models. We reflected higher interest rates. And that resulted in a net release of liabilities, a large portion of which is coming through the CSM. So as Phil noted, the basis change is impacting positively the Asia earnings through a higher CSM balance and slightly faster amortization of CSM that was more mechanical as opposed to anything that we did on the amortization.

Steve, just to follow up on that. So the faster amortization of CSM is a permanent thing or did it just affect this quarter?

No, that would be an ongoing run rate.

The next question is from Nigel D'Souza from Veritas Investment Research.

I wanted to dig into the actuarial review this quarter. And I noticed that when it comes to experience, the experience since COVID-19 pandemic, I believe, was excluded from the review. I'm just trying to get a sense of how you determined which experiences in 2020 was an outlier versus what could be more indicative of post-COVID experience and how that factored into the review this quarter.

It's Steve. So how we dealt with COVID in the review is, for long-term insurance products, where we felt that that the experience during COVID was not indicative of what long-term trends would be, we excluded that experience. And that's consistent with industry practice. And I'll just point to a comment that I made on one of the earlier questions. For instance, in Canada, the level COI lapse study that we did, we did not include the COVID experience there. But as I noted, experiences already trended back towards the pre-pandemic levels. Where we did reflect more recent experience was on certain morbidity assumptions, where we believe that the experience more recently is indicative of future trends. And that actually strengthened reserves on the morbidity side in Vietnam and was partially offset in Japan. So that's the approach that we took. And as I noted, it's consistent with industry standards as well.

Any comments on mortality? You covered lapse and morbidity, but any thoughts on the mortality experience since 2020?

The review that we did in US life, we updated mortality assumptions. That was based on our own experience before the pandemic, as well as an additional industry study. I would remind you that – it was a modest change in my view, in total. I would remind you that we have a really diversified book of business when it comes to longevity versus mortality. And we saw that through the pandemic, with higher claims in life insurance, fully offset by gains in long-term care and annuities from the mortality trends. So just a reminder that we're well matched on mortality overall.

Just last question on this, any color you have on – if there were some of the trends that end up being a bit more persistent, maybe not indicative of future trends, but just a change – maybe a slight adverse or favorable change from pre-COVID trends, any sense of what the net impact might have been or could be? Just to gauge what the sensitivity would be to some of these COVID trends.

As I noted, the mortality trends, we've got good offsets. The lapse experience is generally trending back towards pre-pandemic levels. So I'm not going to quote a number. We do provide some sensitivities in the MD&A on our liability assumptions. And as you know, we regularly and routinely update based on emerging experience and our view of the future. So we'll continue to do that and be transparent about what judgments that we're making.

The next question is from Mario Mendonca from TD Securities.

Quickly, first on wealth management. I obviously, among other things, focus on the operating leverage in that segment. And while it's been improving, it's also been negative now for some time because expense growth has been so high. It's not the top line, the top line looks pretty solid. So could you speak to what these expenses are? And is there a period when we'd expect expense growth to return to something more sort of normal in the mid-single digits?

It's Paul here. Just on the overall margin, just relative to last year's results. One is just a reduction in repatriation of seed capital in some private assets that brought down the core earnings. And then the step up acquisition of our China JV, Manulife Fund Management also had an impact overall on the margin year-over-year. The third impact was expense growth, as you noted. Coming into COVID, we did see an increase in expense growth to support the growth of our business, but we recognized that in Q1 of this year, and just looking at the uncertain markets, started taking actions then internally here. And you've seen that come through the expense growth since then. It was down from Q2 to Q1 and Q3 was pretty flat with Q2. What I will say is that expense growth is a continued focus for us in the business. That's something that we're looking at how do we get leverage out of the global franchise, and more importantly, you've heard Roy talk about our digital ambition and the investments we're making there. And we expect that to pay dividends for us. So we are expecting to have more muted expense growth going forward for our business based on those efficiencies that we see. And then just looking forward from a margin perspective, we can't control markets, obviously. And that drives a lot of our fee income. But if you look at some of the other metrics, the top line, as you mentioned, has been very strong, $5.3 billion year-to-date, 12 out of 13 years. And then the other thing I'd say is our net interest fee yield has also been pretty stable. So when we look at that, our focus on expenses and net flows, we feel very optimistic that we'll continue to improve this margin over time.

Moving to ALDA again, and it's a different kind of question, depending on which economist you speak to, we'd expect rates to start to come down – like, overnight rates start coming down, say, around April or May. The question is, how soon after rates start to drop to the short end of the curve or the long end of the curve, how soon after do you actually start to report some gains on the ALDA? Like, returns that are above your long-term expectations? Is that a reasonable expectation as rates start to fall?

It's not all about interest rates, but interest rates obviously have been pressuring returns this year. And to the extent the Fed does start to lower rates, that will certainly be helpful. And I think appraisers will actually reflect that pretty quickly. Or even based on sort of market expectations. So, yes, I would think on the real estate side, you should see that sort of reversal. Of course, there's other factors at play, how's the general economy doing and so forth, that will also have an impact?

And the next question is from Tom MacKinnon from BMO Capital Markets.

Just to follow up on all the ALDA discussions. We've been focusing here, talking a lot on cap rates, but obviously, the return on the portfolio, not just the cap rates, it's the growth and as the dynamics of sort of commercial real estate are changing, what are your thoughts on that growth? It's a different world post COVID here now in terms of commercial real estate, so how does that factor in? Just your comments with respect to that?

As I talked about earlier, for commercial real estate, cap rates plus growth, to your point, are what drive the total returns. And our portfolio is office, industrial, multifamily. And I would say on the office side, I would say growth could be challenged. It's hard to say for sure. This return to office has still not played out. But that's something we're keeping a watching brief on. But our office has become a pretty small part of our ALDA portfolio. The US office is only 5% of the overall ALDA portfolio at this point. Whereas I think the other property types really have pretty good tailwinds behind them. In industrial, we've seen a lot of growth there. Would expect that to continue. And then, on multifamily, there's certainly a shortage of housing, which I think bodes well in the long run. So I'm feeling pretty positive on the growth of two of the three sectors that we have. And for office, I think the jury's still out.

Tom, Roy here. I might just also chime in and add that our real estate portfolio is actually quite globally diverse as well. 38% is in the US, 33% in Canada and 29% in Asia. And we've seen, on the point of valuations, Asia hold up actually quite well. So the diversity of the portfolio is also another factor that just needs to be in the back of people's minds.

Thank you. There are no further questions registered at this time. I'd like to turn the meeting back over to Mr. Ko.

Thank you, operator. We'll be available after the call if there are any more questions. Have a good day, everyone.

Thank you. The conference has now ended. Please disconnect your lines at this time. And we thank you for your participation.